Press Releases
EndoGastric Solutions Announces First Use and Limited Market Release of Next-Generation Version of EsophyX® Device
Latest EsophyX® Z Fastener Delivery System Significantly Reduces the Number of Steps in the TIF® (Transoral Incisionless Fundoplication) Procedure REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal...
Meta-Analysis Provides Wide-Ranging Proof EndoGastric Solutions’ Transoral Incisionless Fundoplication (TIF®) Procedure Successfully Treats GERD
REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today the results of a meta-analysis demonstrating that EGS’ Transoral Incisionless Fundoplication (TIF®) procedure...
EndoGastric Solutions to Present Meta-Analysis Data on TIF Procedure for Treatment of GERD at DDW 2016
Product Theater Session to Provide Key Updates on Procedure Clinical Data and Reimbursement REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that the company...
EndoGastric Solutions to Present Meta-Analysis Data on TIF Procedure for Treatment of GERD at DDW 2016
Product Theater Session to Provide Key Updates on Procedure Clinical Data and Reimbursement REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that the company...
FDA Clears Next-Generation Version of EndoGastric Solutions’ EsophyX Device
EsophyX® Z Fastener Delivery System requires fewer steps for Transoral Incisionless Fundoplication (TIF) procedures REDMOND, Washington—EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today...
3 Year TEMPO Data Presented at SAGES Finds EndoGastric Solution’s Transoral Incisionless Fundoplication (TIF®) Procedure Offers Long-term Control of Chronic GERD Symptoms
Longest follow-up data from randomized controlled trial available REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced the presentation of three-year follow-up data...
EndoGastric Solutions Secures $50 Million In Financing
CRG Joins Existing Investors In New Financing Deal In Support Of Commercialization Plans Redmond, Washington. – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that it has secured...
EndoGastric Solutions Names Michael K. Burke Chief Financial Officer
Industry veteran offers 30 years of banking and corporate finance leadership experience Redmond, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced today that industry veteran...
EndoGastric Solutions Announces Assignment of Relative Value Units For New CPT Code Covering TIF Procedure
Ambulatory Payment Classification Assignment Also Included In The Federal Register REDMOND, Washington – EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced the Federal Register has...